Avances terapéuticos en el tratamiento del cáncer de ovario: OLAPARIB: primer inhibidor de PARP - page 23

Treating HR Proficient Tumors: Overcoming

Primary Resistance

Konstantinopoulos et al. Cancer Discov. 2015

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,13,14,15,16,17,18,19,20,21,22 24,25,26,27,28,29,30,31,32,...33